Tumor type | Number of cases (n) | Mean age (years) | Median age (years) | Female patients (%) | Specimen site (% samples in each tumor type) | ||
Primary site | Metastatic | Ambiguous or unknown | |||||
NSCLC | 199 | 69.7 | 69.0 | 41.7 (n=83) | 52.8 (n=105) | 30.7 (n=61) | 16.6 (n=33) |
Gastrointestinal | 70 | 65.7 | 65.5 | 55.7 (n=39) | 28.6 (n=20) | 54.3 (n=38) | 17.1 (n=12) |
Gynecological | 37 | 64.1 | 67.0 | 100 (n=37) | 27.0 (n=11) | 32.4 (n=12) | 37.8 (n=14) |
Genitourinary | 19 | 72.3 | 72.0 | 0 (n=0) | 52.7 (n=10) | 26.3 (n=5) | 21.1 (n=4) |
Neuroendocrine tumor | 17 | 68.7 | 70.0 | 41.2 (n=7) | 17.6 (n=3) | 58.8 (n=12) | 11.8 (n=2) |
Head and neck tumor | 7 | 57.6 | 62.0 | 71.4 (n=5) | 0 (n=0) | 57.1 (n=4) | 42.9 (n=3) |
Melanoma | 16 | 70.6 | 73.0 | 31.3 (n=5) | 50 (n=8) | 37.5 (n=6) | 12.5 (n=2) |
Soft tissue | 15 | 59.4 | 63.0 | 46.7 (n=7) | 60.0 (n=9) | 13.3 (n=2) | 26.7 (n=4) |
Central nervous system | 10 | 51.3 | 53.5 | 50.0 (n=5) | 90.0 (n=9) | 0 (n=0) | 10.0 (n=1) |
Unknown primary malignant neoplasm | 28 | 63.2 | 69.0 | 46.4 (n=13) | N/A | N/A | N/A |
Total | 418 | 67.3 | 68.5 | 48.1 (n=201) | 39.0 (n=163) | 32.8 (n=137) | 28.2 (n=118) |
NSCLC, non-small cell lung cancer.